Skip to main content
. 2018 Feb 23;13(2):e0193125. doi: 10.1371/journal.pone.0193125

Fig 2. Gastric cancer-specific survival presented by the Kaplan-Meier method.

Fig 2

Negative (no staining) versus positive (weak, moderate, and strong positive staining) UCHL5 immunoexpression was compared in A) the whole patient cohort, B) patients with stages I-II of the disease, C) patients with small (<5 cm) tumor size, and D) patients 66 or older. The log rank-test was used for calculating the p value.